Medicine Description cytarabine-human-care 50mg
Cytarabine 50 mg injection is a medication that functions as an antimetabolite, specifically mimicking the nucleoside cytidine. Once inside the cancer cell, it gets phosphorylated to its active form, cytarabine triphosphate. This metabolite competes with the natural nucleoside for incorporation into DNA. By embedding itself into the DNA strand, Cytarabine disrupts DNA synthesis and repair, which causes the cells to undergo apoptosis, effectively halting the proliferation of malignant cells. This action is particularly potent in rapidly dividing cells, such as those found in acute leukemias, making it a cornerstone in the chemotherapy regimens for these conditions.
Indications and Uses of Cytarabine 50 mg injection
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Central Nervous System Leukemia
- Other hematological malignancies as determined by a healthcare provider
Side Effects of Cytarabine 50 mg injection
- Nausea and vomiting
- Bone marrow suppression
- Mucositis
- Fatigue
- Rash
- Elevated liver enzymes
- Fever
- Allergic reactions
Storage and Handling
Cytarabine should be stored at room temperature, away from light and moisture. It must not be frozen, and any unused solution should be discarded according to local regulations.
Patient Advice and Precautions
Patients receiving Cytarabine should be monitored closely for signs of infection or bleeding due to its effects on bone marrow. Staying hydrated during treatment may help reduce certain side effects. It is crucial to inform healthcare providers about any existing health conditions or medications being taken to avoid potential interactions.